Analyst Ratings For Abcam Plc (LON:ABC)
Today, Numis Securities reiterated its Hold rating on Abcam Plc (LON:ABC).
There are 3 Hold Ratings, 1 Sell Ratings, 1 Buy Ratings, no Strong Buy Ratings on the stock.
The current consensus rating on Abcam Plc (LON:ABC) is Hold with a consensus target price of GBX 1,282.75 per share, a potential .
Some recent analyst ratings include
- 9/11/2018-Abcam Plc (LON:ABC) had its Hold rating reiterated by Numis Securities
- 9/10/2018-Abcam Plc (LON:ABC) had its Hold rating reiterated by Peel Hunt with a GBX 1,100 price target
- 9/11/2017-Abcam Plc (LON:ABC) had its Sell rating reiterated by Panmure Gordon
- 5/2/2017-Abcam Plc (LON:ABC) had its Hold rating reiterated by Stifel Nicolaus with a GBX 890 price target
About Abcam Plc (LON:ABC)
Abcam plc, together with its subsidiaries, produces and distributes research-grade antibodies and associated protein research tools worldwide. The company primarily offers primary and secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selectors, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers, and tools and reagents. Its products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics and nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells, as well as in drug discovery products and services. Abcam plc also engages in sales and distribution, and financing and investing activities, as well as sells its products online. It offers validated antibodies and other binders, and assays to the research and clinical communities to help advance the understanding of biology and causes of disease. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.
Recent Trading Activity for Abcam Plc (LON:ABC)
Shares of Abcam Plc closed the previous trading session at 1,313.00 up +55.00 4.37% with 88.2 shares trading hands.
